Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare Professionals.

breastfeeding community health services drug information services drug safety information seeking behavior lactation medication obstetrics pregnancy public health

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
14 07 2022
Historique:
received: 20 06 2022
revised: 11 07 2022
accepted: 12 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

A Teratology Information Service (TIS) does not exist in Belgium yet but will hopefully be established soon. To prepare for this, we aimed to provide insight into the information needs and counseling preferences of the Belgian public and healthcare professionals (HCPs) regarding medication use in pregnancy and breastfeeding. A cross-sectional study using two anonymous, online surveys disseminated via social media, websites, and newsletters addressing Dutch and French-speaking individuals (≥18 years) and licensed HCPs was performed between June and September 2020. Ethics approval and informed consent were obtained. In total, 1508 public survey respondents (98% women) and 702 HCPs participated. Information needs on perinatal medication use were ubiquitous among both groups, and for which they often relied on patient information leaflets or the product information and online fora. Conflicting information on this topic regularly occurs and complicates HCPs' duties. Women and HCPs assigned an important role to a TIS, both in terms of providing evidence-based information (via a website or app) and being accessible to be contacted in case of questions (by phone or via e-mail or chat). In conclusion, a TIS would be warmly welcomed by women and HCPs in Belgium and should ideally be established soon to address current information needs regarding perinatal medication use and to contribute to research in this field.

Identifiants

pubmed: 35886455
pii: ijerph19148605
doi: 10.3390/ijerph19148605
pmc: PMC9319400
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Z Geburtshilfe Neonatol. 2018 Feb 08;:
pubmed: 29421836
Int J Clin Pharm. 2017 Aug;39(4):783-790
pubmed: 28626851
Aust N Z J Obstet Gynaecol. 2009 Apr;49(2):168-72
pubmed: 19432605
Reprod Toxicol. 2005 Sep-Oct;20(3):331-43
pubmed: 15978773
Obstet Med. 2016 Sep;9(3):130-4
pubmed: 27630750
Breastfeed Med. 2022 Feb;17(2):93-97
pubmed: 35073165
Basic Clin Pharmacol Toxicol. 2022 Jan;130(1):171-181
pubmed: 34587362
J Eval Clin Pract. 2010 Oct;16(5):957-63
pubmed: 20590976
Reprod Toxicol. 2017 Jan;67:26-34
pubmed: 27851994
Pharmacoepidemiol Drug Saf. 2013 Mar;22(3):324-8
pubmed: 23359404
Aust J Gen Pract. 2018 Dec;47(12):883-888
pubmed: 31212410
Expert Opin Drug Saf. 2021 Sep;20(9):1117-1124
pubmed: 34080506
Biomed Pharmacother. 2021 Apr;136:111038
pubmed: 33526310
Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):195-200
pubmed: 21748849
J Med Internet Res. 2014 Feb 20;16(2):e60
pubmed: 24565696
Eur J Clin Pharmacol. 2018 Feb;74(2):171-179
pubmed: 29063150
Am J Med Genet C Semin Med Genet. 2011 Aug 15;157C(3):175-82
pubmed: 21766440
Drug Saf. 2019 Jan;42(1):1-12
pubmed: 30246225
Swiss Med Wkly. 2021 Nov 28;151:w30048
pubmed: 34843179
BMJ Open. 2014 Feb 17;4(2):e004365
pubmed: 24534260
Eur J Clin Pharmacol. 2010 Feb;66(2):207-14
pubmed: 19841915
Eur J Clin Pharmacol. 2019 Jul;75(7):995-1003
pubmed: 30834472
Int J Clin Pharm. 2016 Aug;38(4):968-76
pubmed: 27241342
Reprod Toxicol. 2017 Jan;67:79-84
pubmed: 27915015
Br J Clin Pharmacol. 2018 Mar;84(3):568-578
pubmed: 29215149
Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1231-1238
pubmed: 31342605
J Eval Clin Pract. 2020 Jun;26(3):911-917
pubmed: 31298801
Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1224-1232
pubmed: 34053137
Women Birth. 2020 Feb;33(1):e48-e58
pubmed: 30545755
Neurology. 2016 Jun 14;86(24):2251-7
pubmed: 27194385
BMJ Open. 2013 Apr 26;3(4):
pubmed: 23624989
Int J Environ Res Public Health. 2022 Apr 27;19(9):
pubmed: 35564733
Int J Environ Res Public Health. 2022 Apr 02;19(7):
pubmed: 35409928
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Rheumatology (Oxford). 2018 Jul 1;57(suppl_5):v34-v39
pubmed: 30137588
Prenat Diagn. 2020 Aug;40(9):1168-1177
pubmed: 32524623
Br J Clin Pharmacol. 2019 Nov;85(11):2580-2590
pubmed: 31378978
Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:189-91
pubmed: 27132709
Birth Defects Res. 2021 Sep 1;113(15):1152-1155
pubmed: 33893758
Birth Defects Res. 2020 Nov;112(18):1545-1550
pubmed: 32840950
Reprod Toxicol. 2007 Feb;23(2):125-32
pubmed: 17184969
Midwifery. 2011 Feb;27(1):80-6
pubmed: 19782445
Z Geburtshilfe Neonatol. 2022 Feb;226(1):48-55
pubmed: 34293814
Matern Child Health J. 2020 May;24(5):531-536
pubmed: 32185571
N Engl J Med. 2019 Apr 4;380(14):1296-1297
pubmed: 30943334
Front Pharmacol. 2022 Jun 15;13:881084
pubmed: 35784689

Auteurs

Michael Ceulemans (M)

Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
Teratology Information Service, Netherlands Pharmacovigilance Centre Lareb, 5237 MH Hertogenbosch, The Netherlands.
L-C&Y, Child and Youth Institute, KU Leuven, 3000 Leuven, Belgium.

Kristel Van Calsteren (K)

Department of Obstetrics & Gynecology, University Hospitals Leuven Gasthuisberg, 3000 Leuven, Belgium.
Woman and Child, Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.

Karel Allegaert (K)

Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
L-C&Y, Child and Youth Institute, KU Leuven, 3000 Leuven, Belgium.
Woman and Child, Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.
Department of Clinical Pharmacy, Erasmus MC, 3000 CA Rotterdam, The Netherlands.

Veerle Foulon (V)

Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH